---
title: Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock
date: '2024-04-08'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38587239/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&fc=20211015124055&ff=20240409180652&v=2.18.0.post9+e462414
source: N Engl J Med
description: 'CONCLUSIONS: The routine use of a microaxial flow pump with standard
  care in the treatment of patients with STEMI-related cardiogenic shock led to a
  lower risk of death from any cause at 180 days than standard care alone. The incidence
  of a composite of adverse events was higher with the use of the microaxial flow
  pump. (Funded by the Danish Heart Foundation and Abiomed; DanGer Shock ClinicalTrials.gov
  number, ...'
disable_comments: true
---
CONCLUSIONS: The routine use of a microaxial flow pump with standard care in the treatment of patients with STEMI-related cardiogenic shock led to a lower risk of death from any cause at 180 days than standard care alone. The incidence of a composite of adverse events was higher with the use of the microaxial flow pump. (Funded by the Danish Heart Foundation and Abiomed; DanGer Shock ClinicalTrials.gov number, ...